SLS - SELLAS Life Sciences Group Inc
IEX Last Trade
1.29
-0.010 -0.775%
Share volume: 535,683
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.01
-0.77%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
| Report Date | 2022-05-12 | 2022-08-11 | 2022-11-14 | 2023-03-16 | |
| Cash flow financing | 47.000 K | 22.996 M | 107.000 K | 929.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -7.150 M | -5.761 M | -5.746 M | -5.152 M | |
| Net income | -16.744 M | -8.414 M | -7.022 M | -9.121 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 1.000 M | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | -4.500 M | |
| Net Borrowings | -16.739 M | -28.637 M | -22.505 M | -17.656 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 14.252 M | 26.987 M | 21.348 M | 17.125 M |